SOX2 and non-small cell lung carcinoma: Annexin I, a phospholipid-binding protein has also been described as including autoantibodies, SOX2 was reported to induce autoantibody responses in SCLC77,78, indicating that autoantibodies to SOX2 could serve as good markers for SCLC, but are not appropriate for NSCLC.